Elanco Animal Health (ELAN) Change in Cash (2017 - 2026)
Elanco Animal Health (ELAN) reported Change in Cash of -$117.0 million for Q1 2026, down 715.79% on a YoY basis from $19.0 million in Q1 2025, and down 392.5% sequentially from $40.0 million in Q4 2025.
Elanco Animal Health (ELAN) Change in Cash (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Change in Cash data on file, last reported at -$117.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 715.79% year-over-year to -$117.0 million; the trailing twelve-month figure through Mar 2026 stood at -$59.0 million (down 141.55% YoY), and the FY2025 full-year result was $77.0 million, down 33.62% from the prior year.
- Change in Cash retreated to -$117.0 million in Q1 2026, from $40.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $165.0 million in Q2 2022 to a low of -$296.0 million in Q1 2022.
- A 5-year average of -$12.4 million and a median of -$7.0 million in 2024 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash tumbled 3388.89% in 2022 and soared 3600.0% in 2024, its largest moves.
- Tracing ELAN's Change in Cash over 5 years: stood at -$115.0 million in 2022, then surged by 85.22% to -$17.0 million in 2023, then retreated by 29.41% to -$22.0 million in 2024, then surged by 281.82% to $40.0 million in 2025, then tumbled by 392.5% to -$117.0 million in 2026.
- Business Quant data shows ELAN's Change in Cash at -$117.0 million in Q1 2026, $40.0 million in Q4 2025, and -$34.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 15.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117.00 Mn |
| Dec 31, 2025 | 40.00 Mn |
| Sep 30, 2025 | -34.00 Mn |
| Jun 30, 2025 | 52.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Dec 31, 2024 | -22.00 Mn |
| Sep 30, 2024 | 74.00 Mn |
| Jun 30, 2024 | 71.00 Mn |
| Mar 31, 2024 | -7.00 Mn |
| Dec 31, 2023 | -17.00 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 49.00 Mn |
| Mar 31, 2023 | -27.00 Mn |
| Dec 31, 2022 | -115.00 Mn |
| Sep 30, 2022 | -47.00 Mn |
| Jun 30, 2022 | 165.00 Mn |
| Mar 31, 2022 | -296.00 Mn |
| Dec 31, 2021 | 185.00 Mn |
| Sep 30, 2021 | -127.00 Mn |
| Jun 30, 2021 | 65.00 Mn |